Φορτώνει......
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
OBJECTIVE: To evaluate the safety and efficacy of cholecalciferol in patients with relapsing-remitting MS (RRMS). METHODS: In this double-blind, placebo-controlled parallel-group, 2-year study, 181 patients with RRMS were randomized 1:1. Key inclusion criteria were a low serum 25-hydroxy vitamin D (...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6705622/ https://ncbi.nlm.nih.gov/pubmed/31454777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000597 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|